Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $26.0 million.

  • Amphastar Pharmaceuticals' Prepaid Assets rose 4682.05% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.0 million, marking a year-over-year increase of 4682.05%. This contributed to the annual value of $18.2 million for FY2024, which is 10110.41% up from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Prepaid Assets of $26.0 million as of Q3 2025, which was up 4682.05% from $20.3 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Prepaid Assets registered a high of $26.0 million during Q3 2025, and its lowest value of $5.9 million during Q2 2023.
  • For the 5-year period, Amphastar Pharmaceuticals' Prepaid Assets averaged around $10.5 million, with its median value being $7.6 million (2022).
  • Its Prepaid Assets has fluctuated over the past 5 years, first crashed by 3447.82% in 2021, then soared by 18603.94% in 2024.
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Prepaid Assets stood at $7.3 million in 2021, then increased by 3.97% to $7.6 million in 2022, then grew by 19.75% to $9.1 million in 2023, then soared by 101.1% to $18.2 million in 2024, then soared by 42.86% to $26.0 million in 2025.
  • Its last three reported values are $26.0 million in Q3 2025, $20.3 million for Q2 2025, and $17.8 million during Q1 2025.